Haemonetics to acquire Cardiva Medical for up to $510 million

Haemonetics agreed to acquire Cardiva Medical, a manufacturer of vascular closure systems, for $475 million upfront plus up to $35 million in contingent consideration, expected to close in Q1 2021.

“Haemonetics will acquire Cardiva for an upfront cash payment of $475 million at closing and up to an additional $35 million in contingent consideration based on sales growth.”prnewswire.com

• 1 source
• prnewswire.comHaemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital PortfolioHaemonetics CorporationJan 20, 2021

Summarized from public sources; check the original articles before acting on it.